Previous 10 | Next 10 |
Meta ( NASDAQ: META ) represented one of the biggest name stocks seeing a midday move on Friday. Shares of the Facebook parent edged lower as it cut back on its hiring plans in the face of a cautious economic forecast. Meanwhile, PureCycle ( PCT ) also made the list of midda...
Gainers: Allena Pharmaceuticals ( ALNA ) +46% . Mega Matrix ( MTMT ) +43% . Faraday Future Intelligent Electric ( FFIE ) +30% . Tyra Biosciences ( TYRA ) +29% . Omeros ( OMER ) +28% . Clovis Oncology ( CLVS ) +22% . ...
Gainers: Accolade ( ACCD ) +18% . Clovis Oncology ( CLVS ) +18% . Larimar Therapeutics ( LRMR ) +14% . Tyra Biosciences ( TYRA ) +13% . VectivBio Holding ( VECT ) +13% . Losers: Talaris Therapeutics ( TALS ) -48% . Agile Therapeu...
The following slide deck was published by Accolade, Inc. in conjunction with their 2023 Q1 earnings call. For further details see: Accolade, Inc. 2023 Q1 - Results - Earnings Call Presentation
Accolade, Inc. (ACCD) Q1 2023 Earnings Conference Call June 30, 2022 04:30 p.m. ET Company Representatives Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Todd Friedman - Senior Vice Preside...
Accolade press release ( NASDAQ: ACCD ): Q1 GAAP EPS of -$4.92 misses by $4.18 . Revenue of $85.5M (+43.7% Y/Y) beats by $3.53M . Revenue between $82 million and $83.5 million for the fiscal second quarter ending August 31, 2022. Adjusted EBITDA between $(1...
Fiscal first quarter 2023 revenue of $85.5 million, a 44% increase compared to fiscal first quarter 2022 revenue of $59.5 million SEATTLE, June 30, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2...
Gainers: Seres Therapeutics (MCRB) +8%. Sana Biotechnology (SANA) +5%. Aziyo Biologics (AZYO) +4%. eXp World Holdings (EXPI) +4%. Aurora Innovation (AUR) +3%. Losers: Trip.com Group (TCOM) -9%. Xenon Pharmaceuticals (XENE) -8%. Accolade (ACCD) -6%. Ikena Oncology (IKNA) -6%. Cerus (...
Accolade to showcase Personalized Healthcare for health plans at AHIP 2022 PR Newswire Accolade and Priority Health will discuss how Personalized Healthcare can deliver value for health plans seeking virtual first solutions for whole person care. SEATTLE ...
SEATTLE, June 21, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal first quarter 2023 financial results on Thursday, June 30, 2022, after the market closes. ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...